{ "model": { "rank": 4815, "code": "thing-q69488", "model_id": "vr.tr.mdma", "name": "MDMA", "purpose": "Enable an agent to identify MDMA, assess the identity and condition of a particular sample, and determine which handling, testing, storage or transfer actions require further evidence or authorization.", "family": "Thing Registry", "category": "Physical world and living systems", "status": "research-draft", "kind": "thing", "plane": "PHY", "domain": "PHY.MAT", "industry": "", "version": "", "url": "/models/thing/q69488/", "tier": 2, "score": 72, "payload": { "layer": "wikidata", "aliases": [ "S-(+)-MDMA", "R-(-)-MDMA" ], "aliasCount": 2, "merged": 2, "knownIn": 72, "facets": null, "markers": [], "lexicalClass": "", "senseRank": null, "alsoRegisteredAs": null, "source": { "dataset": "wikidata", "item": "Q69488", "url": "https://www.wikidata.org/wiki/Q69488", "license": "CC0 1.0" } }, "research": { "vercy": "1.0-draft", "publication": { "status": "research-draft", "adjudicationStatus": "unreviewed", "publishableCanonical": false, "generatedAt": "2026-09-09T21:03:07Z", "providers": [ "Codex" ], "breadth": "recalled by Codex without web access - no source was read", "missingProviders": [], "pass": 2, "cost": { "grok": { "seconds": 20, "error": "Reading additional input from stdin...\nOpenAI Codex v0.153.4\n--------\nworkdir: R:\\02_PROJECTS\\02_Meta_Models_Platforms\\Ver.cy\\current\\thing-registry-backlog\nmodel: gpt-6-astra\nprovider: openai\napproval: never\nsandbox: read-only\nreasoning effort: none\nreasoning summaries: none\nsession id: 01a087fa-3eb2-70b0-a494-ae510b0e2d20\n--------\nuser\nDescribe what is already known about one registered thing. Answer as JSON only, no prose around it.\n\nThing: MDMA\nSense to describe: (none recorded)\nDomain code: PHY.MAT\nAlso known as: (none)\n\n\nContext for this batch of 1001 things:\n# Batch 005: 1001 registered", "usd": 0, "recall": true }, "codex": { "seconds": 68.8, "error": "Reading additional input from stdin...\nOpenAI Codex v0.153.4\n--------\nworkdir: R:\\02_PROJECTS\\02_Meta_Models_Platforms\\Ver.cy\\current\\thing-registry-backlog\nmodel: gpt-6-astra\nprovider: openai\napproval: never\nsandbox: read-only\nreasoning effort: none\nreasoning summaries: none\nsession id: 01a087fa-3ea1-7be0-9074-342b93a5e916\n--------\nuser\nYou are drafting a Vercy meta-model for one registered thing. Answer as JSON only, no prose around it.\n\nThing: MDMA\nRegistry id: vr.tr.mdma\nPlane / domain: PHY / PHY.MAT\nRegistry definition: (none recorded)\nNames folded into this entry: (none)\n\n\nContext for th" } } }, "metaModel": { "id": "THING-Q69488", "registryId": "vr.tr.mdma", "name": "MDMA", "version": "0.1.0-research.1", "entryKind": "thing", "family": "Thing Registry", "domain": [ "PHY.MAT" ], "status": "research-draft" }, "canonicalUrl": "https://ver.cy/models/thing/q69488/", "model": { "registry_id": "vr.tr.mdma", "name": "MDMA", "purpose": "Enable an agent to identify MDMA, assess the identity and condition of a particular sample, and determine which handling, testing, storage or transfer actions require further evidence or authorization.", "definition": "MDMA (3,4-methylenedioxymethamphetamine) is a synthetic chiral substituted amphetamine, molecular formula C11H15NO2, whose psychoactive effects arise primarily from increased serotonin, norepinephrine and dopamine signalling.", "scope_statement": "This model owns MDMA as a chemical substance under registry entry vr.tr.mdma in PHY / PHY.MAT, including molecular and stereochemical identity, free-base and salt forms, sample composition, physical condition, hazards and jurisdiction-specific controls; it distinguishes the substance from products containing it and from activities involving its use.", "in_scope": [ "Molecular identity of 3,4-methylenedioxymethamphetamine, including stereochemistry and form-specific identifiers", "Free-base and salt forms, with counterion, hydration and reporting basis recorded explicitly", "Sample identity, MDMA content, purity, impurities, adulterants and analytical uncertainty", "Physical properties and stability tied to chemical form and measurement conditions", "Substance-specific biological hazards and evidence relevant to exposure assessment", "Regulatory identity and documented permissions for a specified jurisdiction and activity" ], "out_of_scope": [ "Tablets, capsules or other formulated products as complete products", "Manufacturing routes, precursor procurement and synthesis procedures", "Individual exposure events, diagnoses and clinical treatment decisions", "Psychotherapy protocols and clinical-trial operations", "Distribution networks, markets and recreational-use practices" ], "distinguishing_features": [ "Require analytical evidence consistent with the 3,4-methylenedioxy ring substitution and N-methylated amphetamine structure; a street name, logo or appearance does not establish MDMA identity.", "Distinguish MDMA from MDA and related substances through an analytical method capable of resolving those identities.", "Distinguish free-base MDMA from a specified salt by recording the counterion and the chemical basis used for identity, mass and concentration.", "Distinguish an unspecified stereochemical composition, a racemic mixture and an enantiomerically enriched material using appropriate evidence.", "Distinguish the presence of MDMA in a mixture from a claim that the sample consists predominantly of MDMA or meets a stated purity specification." ], "characteristics": [ { "name": "Chemical identity and identifier agreement", "kind": "category", "unit_or_values": "Verified chemical name and structure; CAS, PubChem CID and EC identifiers where applicable, each associated with its chemical form", "why_it_matters": "Prevents identifiers for different salts, stereochemical forms or related compounds from being treated as interchangeable." }, { "name": "Chemical form", "kind": "category", "unit_or_values": "Free base; identified salt with counterion and stoichiometry; unresolved form", "why_it_matters": "Physical properties and quantitative reporting depend on which form is present." }, { "name": "Stereochemical composition", "kind": "measurement", "unit_or_values": "Enantiomer ratio or enantiomeric excess in %, with method; unspecified when unmeasured", "why_it_matters": "A non-chiral identity result does not establish the relative amounts of the enantiomers." }, { "name": "MDMA content", "kind": "measurement", "unit_or_values": "Mass fraction %, mg/g or mg/mL, with free-base or salt basis, uncertainty and sampling basis", "why_it_matters": "Makes results comparable without confusing salt mass, mixture mass and MDMA-equivalent content." }, { "name": "Impurity and adulterant profile", "kind": "measurement", "unit_or_values": "Identified substances and concentrations, plus unknown signals and method-specific detection limits", "why_it_matters": "A positive MDMA identification leaves other constituents and their hazards unresolved." }, { "name": "Physical and thermal properties", "kind": "measurement", "unit_or_values": "Phase at stated temperature and pressure; melting or decomposition behavior in °C; solubility in g/L for a stated solvent and temperature", "why_it_matters": "Supports form-specific identification and handling without importing constants from a different material." }, { "name": "Sample condition", "kind": "state", "unit_or_values": "Within specification; changed from baseline; degraded; insufficient evidence", "why_it_matters": "Connects storage history and repeat analysis to the sample's current suitability." }, { "name": "Hazard evidence", "kind": "relation", "unit_or_values": "Links to form-specific safety documentation, toxicology evidence and applicable hazard classifications", "why_it_matters": "Separates established substance hazards from uncertain hazards introduced by sample composition." }, { "name": "Activity-specific regulatory status", "kind": "relation", "unit_or_values": "Jurisdiction, effective date, controlled-substance entry, covered forms, proposed activity and authorization record", "why_it_matters": "A substance classification alone does not establish whether a particular actor may perform a particular action." } ], "affordances": [ "Reconcile a sample's claimed MDMA identity with analytical evidence and form-specific identifiers.", "Compare content measurements after aligning salt basis, units, sampling assumptions and uncertainty.", "Identify which additional analyses are needed to resolve stereochemistry, adulterants or uncertain chemical form.", "Assess whether a sample remains within its documented specification using storage history and analytical results.", "Retrieve applicable handling requirements and verify authorization before storage, testing, transfer or disposal." ] }, "sources": [], "structure": { "bundles": [ { "id": "mdma-chemical-identity", "name": "MDMA chemical identity", "description": "Establishes which molecular, stereochemical and salt identity a claim of MDMA denotes.", "rationale": "MDMA identification must distinguish related compounds while preserving the registry's single substance entry.", "layers": [ { "id": "molecular-discrimination", "name": "Molecular discrimination", "description": "Separates MDMA from structurally related substances and unsupported product labels.", "findings": [ { "id": "structure-supported-identity", "name": "Structure-supported identity", "description": "Record whether evidence establishes the MDMA structure and discriminates relevant alternative identities.", "questions": [ { "text": "What structural definition and authoritative identifier records establish the intended MDMA identity?", "kind": "definition", "id": "structure-supported-identity-q01" }, { "text": "Which analytical evidence distinguishes this sample from MDA, related analogues and positional isomers?", "kind": "measurement", "id": "structure-supported-identity-q02" } ] } ] }, { "id": "form-and-stereochemistry", "name": "Form and stereochemistry", "description": "Qualifies molecular identity by salt form and enantiomeric composition.", "findings": [ { "id": "qualified-mdma-form", "name": "Qualified MDMA form", "description": "Record free-base or salt identity separately from the evidence for stereochemical composition.", "questions": [ { "text": "Is the material free-base MDMA or a specified salt, and what establishes its counterion, stoichiometry and hydration state?", "kind": "definition", "id": "qualified-mdma-form-q01" }, { "text": "Has enantiomeric composition been measured, and can the method support a racemic or enantiomerically enriched designation?", "kind": "measurement", "id": "qualified-mdma-form-q02" } ] } ] } ] }, { "id": "mdma-sample-composition", "name": "MDMA sample composition", "description": "Connects a substance identity to the measured composition of a particular sample.", "rationale": "Detecting MDMA does not establish its quantity, purity or the absence of other substances.", "layers": [ { "id": "content-and-reporting-basis", "name": "Content and reporting basis", "description": "Makes quantitative MDMA results interpretable across salts, mixtures and analytical methods.", "findings": [ { "id": "comparable-mdma-content", "name": "Comparable MDMA content", "description": "Record assay values with the chemical and sample basis needed to compare them.", "questions": [ { "text": "What MDMA content was measured, with which units, uncertainty and free-base or specified-salt basis?", "kind": "measurement", "id": "comparable-mdma-content-q01" }, { "text": "Does the result describe the sampled portion, a dry material, a solution or a demonstrably representative batch?", "kind": "boundary", "id": "comparable-mdma-content-q02" } ] } ] }, { "id": "co-constituents-and-confidence", "name": "Co-constituents and confidence", "description": "Records other detected substances and the limits of the analytical examination.", "findings": [ { "id": "bounded-composition-claim", "name": "Bounded composition claim", "description": "Distinguish measured impurities and adulterants from constituents that were untested or unresolved.", "questions": [ { "text": "Which impurities, adulterants, residual solvents or unknown signals were found, and at what concentrations or detection limits?", "kind": "measurement", "id": "bounded-composition-claim-q01" }, { "text": "Which laboratory report, sampling record and reference materials support the composition claim?", "kind": "provenance", "id": "bounded-composition-claim-q02" }, { "text": "Which potential co-constituents fall outside the analytical method's coverage?", "kind": "boundary", "id": "bounded-composition-claim-q03" } ] } ] } ] }, { "id": "mdma-physical-state-and-stability", "name": "MDMA physical state and stability", "description": "Relates observed properties and storage history to the specified MDMA form.", "rationale": "Properties attributed simply to MDMA can obscure differences between free base, salts and mixed samples.", "layers": [ { "id": "form-specific-properties", "name": "Form-specific properties", "description": "Associates physical constants with the material and conditions actually studied.", "findings": [ { "id": "conditioned-property-record", "name": "Conditioned property record", "description": "Record phase, thermal behavior and solubility only with a defined form and measurement context.", "questions": [ { "text": "What phase, melting or decomposition behavior and solubility are supported for this exact MDMA form under stated conditions?", "kind": "measurement", "id": "conditioned-property-record-q01" }, { "text": "Does each cited property concern the free base, a particular salt or a mixture, and is a reported boiling point experimentally established?", "kind": "boundary", "id": "conditioned-property-record-q02" } ] } ] }, { "id": "storage-and-condition-change", "name": "Storage and condition change", "description": "Tracks whether environmental exposure has changed a sample's documented condition.", "findings": [ { "id": "evidenced-sample-stability", "name": "Evidenced sample stability", "description": "Connect storage conditions, packaging and analytical changes to supported stability claims.", "questions": [ { "text": "What temperature, light, moisture and container history is documented for this sample?", "kind": "provenance", "id": "evidenced-sample-stability-q01" }, { "text": "What evidence supports its current storage limits, retest interval or need for reassessment?", "kind": "action", "id": "evidenced-sample-stability-q02" } ] } ] } ] }, { "id": "mdma-biological-hazards", "name": "MDMA biological hazards", "description": "Organizes evidence about MDMA's biological activity and the hazards relevant to a sample.", "rationale": "An agent must distinguish MDMA-specific hazards, mixture hazards and claims that require individual clinical assessment.", "layers": [ { "id": "pharmacological-evidence", "name": "Pharmacological evidence", "description": "Records the evidence and limits behind descriptions of MDMA's biological activity.", "findings": [ { "id": "bounded-activity-claims", "name": "Bounded activity claims", "description": "Associate pharmacological claims with the studied substance, experimental setting and uncertainty.", "questions": [ { "text": "Which primary evidence supports claims about MDMA's monoamine-related activity, and which form or enantiomeric composition was studied?", "kind": "provenance", "id": "bounded-activity-claims-q01" }, { "text": "Which conclusions concern laboratory mechanisms, human effects or a particular formulation, and where does extrapolation remain unresolved?", "kind": "boundary", "id": "bounded-activity-claims-q02" } ] } ] }, { "id": "exposure-and-handling-hazards", "name": "Exposure and handling hazards", "description": "Connects toxicological evidence and sample composition to appropriate handling assessments.", "findings": [ { "id": "sample-relevant-hazard-assessment", "name": "Sample-relevant hazard assessment", "description": "Record applicable hazard evidence without treating an MDMA assay as proof of safety.", "questions": [ { "text": "What evidence addresses hyperthermia, hyponatremia, cardiovascular effects and serotonin toxicity, and under what exposure conditions?", "kind": "provenance", "id": "sample-relevant-hazard-assessment-q01" }, { "text": "Which hazards arise from MDMA itself, identified co-constituents or unresolved sample composition?", "kind": "boundary", "id": "sample-relevant-hazard-assessment-q02" }, { "text": "Which handling controls follow from the applicable safety documentation, and are authoritative occupational exposure limits available?", "kind": "action", "id": "sample-relevant-hazard-assessment-q03" } ] } ] } ] }, { "id": "mdma-regulatory-control", "name": "MDMA regulatory control", "description": "Determines how a specified MDMA identity and proposed activity relate to current legal controls.", "rationale": "MDMA permissions depend on jurisdiction, covered chemical forms, actor and activity rather than a universal legal label.", "layers": [ { "id": "jurisdictional-substance-coverage", "name": "Jurisdictional substance coverage", "description": "Maps the material's identity to the relevant legal entry and its scope.", "findings": [ { "id": "dated-control-mapping", "name": "Dated control mapping", "description": "Record the authoritative control text and whether it covers the specific form or mixture.", "questions": [ { "text": "Which authoritative legal entry governs MDMA in the relevant jurisdiction on the decision date?", "kind": "provenance", "id": "dated-control-mapping-q01" }, { "text": "How does that entry address salts, stereoisomers, preparations and mixtures containing MDMA?", "kind": "boundary", "id": "dated-control-mapping-q02" } ] } ] }, { "id": "authorized-custody-and-actions", "name": "Authorized custody and actions", "description": "Relates proposed handling to documented permissions and custody requirements.", "findings": [ { "id": "activity-specific-permission", "name": "Activity-specific permission", "description": "Establish whether the responsible actor has the permissions required for the proposed action.", "questions": [ { "text": "What current authorization covers this actor's proposed possession, analysis, transfer, import, export or disposal of MDMA?", "kind": "action", "id": "activity-specific-permission-q01" }, { "text": "Which custody, inventory, recipient-verification and disposal records must accompany that action?", "kind": "action", "id": "activity-specific-permission-q02" } ] } ] } ] }, { "id": "evidence-and-external-alignment", "name": "Evidence and external alignment", "description": "What the world already says about this thing, gathered so the model can be checked against it.", "rationale": "A model that cannot be lined up against existing standards, identifiers and practice cannot be adopted by anyone who already uses them.", "layers": [ { "id": "reported-evidence", "name": "Reported evidence", "description": "Findings from the breadth pass, kept separate from the structural claims.", "findings": [ { "id": "evidence-confidence-notes", "name": "Check these first", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "This is recalled knowledge, without consulted sources; verify identifiers before publication.", "Verify current jurisdiction-specific scheduling and therapeutic access before describing legal or clinical availability.", "Physical constants and hazard classifications require the specific salt, stereochemical composition, purity and measurement conditions; none are supplied here." ], "questions": [ { "id": "evidence-confidence-notes-q01", "text": "Which of these check these first hold for the sense of MDMA this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-kinds", "name": "Kinds and varieties", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "Racemic MDMA", "(R)-MDMA", "(S)-MDMA", "MDMA free base", "MDMA hydrochloride" ], "questions": [ { "id": "evidence-kinds-q01", "text": "Which of these kinds and varieties hold for the sense of MDMA this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-identifiers", "name": "Identifiers and schemes", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ { "scheme": "CAS Registry Number", "value_or_pattern": "42542-10-9", "note": "MDMA free base; the hydrochloride salt has a separate identifier." }, { "scheme": "CAS Registry Number", "value_or_pattern": "64057-70-1", "note": "MDMA hydrochloride." }, { "scheme": "PubChem CID", "value_or_pattern": "1615", "note": "MDMA compound record." } ], "questions": [ { "id": "evidence-identifiers-q01", "text": "Which of these identifiers and schemes hold for the sense of MDMA this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-standards-and-regulation", "name": "Standards and regulation", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "United Nations Convention on Psychotropic Substances of 1971: MDMA is listed in Schedule I; national implementation and research permissions differ." ], "questions": [ { "id": "evidence-standards-and-regulation-q01", "text": "Which of these standards and regulation hold for the sense of MDMA this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-real-world-use", "name": "Real-world use", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "Nonmedical use for entactogenic effects, including feelings of emotional closeness, and stimulant effects.", "Investigational use alongside psychotherapy, particularly in research on post-traumatic stress disorder.", "Laboratory research on monoamine transporters and psychoactive drug effects.", "Analytical reference material for forensic and toxicological testing." ], "questions": [ { "id": "evidence-real-world-use-q01", "text": "Which of these real-world use hold for the sense of MDMA this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-measurements", "name": "Typical measurements", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ { "quantity": "Molar mass of free base", "typical_range": "193.24", "unit": "g/mol" }, { "quantity": "Molar mass of anhydrous hydrochloride salt", "typical_range": "229.70", "unit": "g/mol" } ], "questions": [ { "id": "evidence-measurements-q01", "text": "Which of these typical measurements hold for the sense of MDMA this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-failure-modes-and-hazards", "name": "Failure modes and hazards", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "Hyperthermia, potentially progressing to muscle breakdown and organ injury.", "Hyponatraemia associated with impaired water excretion and excessive water intake.", "Serotonin toxicity, especially with interacting serotonergic substances.", "Cardiovascular stress, including increased heart rate and blood pressure.", "Products sold as ecstasy or molly may have variable MDMA content or contain other substances." ], "questions": [ { "id": "evidence-failure-modes-and-hazards-q01", "text": "Which of these failure modes and hazards hold for the sense of MDMA this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-regional-variation", "name": "Regional variation", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "National laws differ in possession penalties, research licensing and permitted medical access.", "Street names and product presentation vary geographically and do not establish chemical identity or purity." ], "questions": [ { "id": "evidence-regional-variation-q01", "text": "Which of these regional variation hold for the sense of MDMA this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-neighbours", "name": "Neighbouring kinds and how to tell them apart", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ { "name": "MDA", "difference": "MDA lacks the N-methyl group present in MDMA and is a distinct psychoactive compound." }, { "name": "Methamphetamine", "difference": "Methamphetamine lacks MDMA's 3,4-methylenedioxy ring substitution." }, { "name": "Ecstasy", "difference": "Ecstasy is a market name for drug products, often tablets; it does not guarantee that their contents are MDMA." }, { "name": "MDMA hydrochloride", "difference": "This is a salt form of MDMA with different formula mass and physical properties from the free base." } ], "questions": [ { "id": "evidence-neighbours-q01", "text": "Which of these neighbouring kinds and how to tell them apart hold for the sense of MDMA this model covers, and on what evidence?", "kind": "provenance" } ] } ] } ] } ] }, "openQuestions": [ "Does an existing Vercy world model already cover MDMA and require this registry entry to link to it instead of receiving a separate publication?", "Which authoritative identifiers apply separately to free-base MDMA, its relevant salts and stereochemical forms?", "Which measured physical constants and stability limits are reliable for each form, particularly where reported thermal values may describe decomposition?", "Which analytical methods and sampling evidence are sufficient for the intended decisions about identity, MDMA content, stereochemistry and co-constituents?", "Which current jurisdiction-specific controls, hazard classifications and occupational exposure guidance apply to the intended setting?" ], "statistics": { "bundles": 6, "layers": 11, "findings": 19, "questions": 31 } }, "draft": { "generator": "vr.draft.v3", "status": "draft-generated", "researched": false, "archetype": "chemical substance or material", "method": "Written from the archetype playbook - what this kind of thing needs beyond identity and provenance - and from the structure that recurred across 6,333 models already researched by two engines. Applied to this entry by rule. No source was read for this thing and no claim here is researched. This entry carries no facets of its own, so they were inferred from its domain - a guess about a whole domain applied to one thing.", "facetsInferred": true, "nextPass": "A researcher replaces this draft with a sourced specification. Treat every sentence below as a proposal to argue with.", "purpose": "Give an agent a durable, checkable way to recognise a MDMA, record what state it is in, and decide what may be done with it.", "whatItIs": "Enable an agent to identify MDMA, assess the identity and condition of a particular sample, and determine which handling, testing, storage or transfer actions require further evidence or authorization.", "characteristics": { "substance": "material", "origin": "natural", "agency": "inert", "mobility": "varies" }, "whatYouCanDoWithIt": [ "observed and measured", "consumed or used up" ], "distinguishingFeatures": [ "Names folded into this entry, which a task may need to split apart again: S-(+)-MDMA, R-(-)-MDMA.", "2 finer distinctions are held as aliases rather than separate entries, because telling them apart needs a task that asks for it.", "Described in 72 Wikipedia languages, which is a measure of how widely the thing is known, not of how important it is." ], "openQuestionsForResearch": [ "Which of the bundles below does a real task actually need, and which are ceremony?", "What does this thing have that the facets do not capture at all?", "Which neighbouring kind is most often confused with a MDMA, and on what evidence are they told apart?" ], "whatItIsMadeOf": "matter you can touch", "physicalCharacter": [ "Mobility varies between examples.", "Does nothing on its own; everything it does, something else did to it.", "These come from the domain this entry sits in rather than from the entry itself, so treat them as a first guess about the whole domain applied to one thing." ], "whatCanBeDoneWithIt": [ "observe it, measure it, record its state", "use it up, and then need more of it" ], "howItIsRecognised": [ "Not recognisable by sight in any reliable way. Appearance varies with grade, form and additives; identification is by label, by documentation, or by assay." ], "relatedModels": [ { "relation": "covers", "note": "Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does.", "targets": [ "S-(+)-MDMA", "R-(-)-MDMA" ] } ], "standing": "Described in 72 Wikipedia languages, which measures how widely it is written about rather than how important or how common it is. 2 finer distinctions are held inside this entry as names rather than as separate models.", "structure": { "bundles": [ { "id": "identity-and-classification", "name": "Identity, naming and classification", "description": "How an agent tells one MDMA from another, and a MDMA from things that resemble it.", "rationale": "Recognition comes before every other claim. Without stable identity nothing else in the model can be trusted to be about the same thing twice.", "layers": [ { "id": "naming-and-identifiers", "name": "Names and identifiers", "description": "The names this thing goes by and the identifiers that survive translation and time.", "findings": [ { "id": "preferred-name-and-aliases", "name": "Preferred name, aliases and local names", "description": "Which name to use, which names mean the same thing, and which merely sound similar.", "questions": [ { "id": "preferred-name-and-aliases-q01", "text": "What identifies and describes the name of a MDMA, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "preferred-name-and-aliases-q02", "text": "Who or what asserted this about the name of a MDMA, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "preferred-name-and-aliases-q03", "text": "What may an agent decide or do once the name of a MDMA is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] }, { "id": "stable-identifiers", "name": "Stable identifiers and external keys", "description": "Identifiers that keep pointing at this kind of thing across systems and languages.", "questions": [ { "id": "stable-identifiers-q01", "text": "What identifies and describes an identifier for a MDMA, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "stable-identifiers-q02", "text": "Who or what asserted this about an identifier for a MDMA, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "stable-identifiers-q03", "text": "What may an agent decide or do once an identifier for a MDMA is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "classification-and-granularity", "name": "Classification and granularity", "description": "Where a MDMA sits among kinds, and how finely a task needs to cut it.", "findings": [ { "id": "kind-and-parents", "name": "Kind, parents and neighbouring kinds", "description": "The classes this thing belongs to and the ones it is next to.", "questions": [ { "id": "kind-and-parents-q01", "text": "What identifies and describes the kind of a MDMA, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "kind-and-parents-q02", "text": "Who or what asserted this about the kind of a MDMA, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "kind-and-parents-q03", "text": "What may an agent decide or do once the kind of a MDMA is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] }, { "id": "distinguishing-features", "name": "Distinguishing features", "description": "What separates a MDMA from the things most often confused with it.", "questions": [ { "id": "distinguishing-features-q01", "text": "What identifies and describes what distinguishes a MDMA, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "distinguishing-features-q02", "text": "Who or what asserted this about what distinguishes a MDMA, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "distinguishing-features-q03", "text": "What may an agent decide or do once what distinguishes a MDMA is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "form-and-composition", "name": "Form, composition and condition", "description": "What a MDMA is made of, what shape and size it takes, and what state it is in.", "rationale": "A physical thing can be measured, and a model that cannot record its measurements cannot support any decision that depends on them.", "layers": [ { "id": "form-and-dimensions", "name": "Form and dimensions", "description": "Shape, size, mass and the ranges these take across examples.", "findings": [ { "id": "measurable-dimensions", "name": "Measurable dimensions and their units", "description": "The quantities worth recording and the units they are recorded in.", "questions": [ { "id": "measurable-dimensions-q01", "text": "What identifies and describes the dimensions of a MDMA, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "measurable-dimensions-q02", "text": "Who or what asserted this about the dimensions of a MDMA, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "measurable-dimensions-q03", "text": "What may an agent decide or do once the dimensions of a MDMA is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "material-and-composition", "name": "Material and composition", "description": "Materials, parts and how they are put together.", "findings": [ { "id": "parts-and-materials", "name": "Parts and materials", "description": "What a MDMA is built from and which parts are replaceable.", "questions": [ { "id": "parts-and-materials-q01", "text": "What identifies and describes the composition of a MDMA, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "parts-and-materials-q02", "text": "Who or what asserted this about the composition of a MDMA, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "parts-and-materials-q03", "text": "What may an agent decide or do once the composition of a MDMA is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "condition-and-integrity", "name": "Condition and integrity", "description": "Wear, damage, health and the difference between working and broken.", "findings": [ { "id": "condition-assessment", "name": "Condition, damage and health", "description": "How the condition of a MDMA is judged and by whom.", "questions": [ { "id": "condition-assessment-q01", "text": "What identifies and describes the condition of a MDMA, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "condition-assessment-q02", "text": "Who or what asserted this about the condition of a MDMA, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "condition-assessment-q03", "text": "What may an agent decide or do once the condition of a MDMA is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "place-and-movement", "name": "Place and movement", "description": "Where a MDMA is, how it got there and where it may go (varies).", "rationale": "A thing that can move needs its position recorded with a time, or every later claim about it is about a place it has left.", "layers": [ { "id": "location-and-placement", "name": "Location and placement", "description": "Position, containment and the reference frame the position is given in.", "findings": [ { "id": "position-and-frame", "name": "Position, container and reference frame", "description": "Where a MDMA is, and what that position is measured against.", "questions": [ { "id": "position-and-frame-q01", "text": "What identifies and describes the location of a MDMA, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "position-and-frame-q02", "text": "Who or what asserted this about the location of a MDMA, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "position-and-frame-q03", "text": "What may an agent decide or do once the location of a MDMA is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "movement-and-transfer", "name": "Movement and transfer", "description": "How a MDMA is carried, installed or relocated.", "findings": [ { "id": "movement-events", "name": "Movement events and constraints", "description": "What counts as a movement, what records it and what limits it.", "questions": [ { "id": "movement-events-q01", "text": "What identifies and describes the movement of a MDMA, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "movement-events-q02", "text": "Who or what asserted this about the movement of a MDMA, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "movement-events-q03", "text": "What may an agent decide or do once the movement of a MDMA is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "state-and-lifecycle", "name": "State and lifecycle", "description": "The states a MDMA passes through and the events that move it between them.", "rationale": "Most decisions about a thing depend on what state it is in now, which is a claim with a time on it, not a property.", "layers": [ { "id": "lifecycle-stages", "name": "Lifecycle stages", "description": "From coming into existence to ceasing to be one of these.", "findings": [ { "id": "stages-and-transitions", "name": "Stages and transitions", "description": "The stages worth naming and what moves a MDMA between them.", "questions": [ { "id": "stages-and-transitions-q01", "text": "What identifies and describes the lifecycle of a MDMA, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "stages-and-transitions-q02", "text": "Who or what asserted this about the lifecycle of a MDMA, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "stages-and-transitions-q03", "text": "What may an agent decide or do once the lifecycle of a MDMA is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "observations-and-status", "name": "Observations and current status", "description": "What is observed about a MDMA, how often and by whom.", "findings": [ { "id": "observation-record", "name": "Observation record", "description": "How an observation of a MDMA is recorded so that it can be superseded rather than overwritten.", "questions": [ { "id": "observation-record-q01", "text": "What identifies and describes an observation of a MDMA, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "observation-record-q02", "text": "Who or what asserted this about an observation of a MDMA, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "observation-record-q03", "text": "What may an agent decide or do once an observation of a MDMA is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "use-and-operation", "name": "Use and operation", "description": "What can be done with a MDMA and what it takes to do it.", "rationale": "An agent that can recognise a thing but not act on it has only half a model.", "layers": [ { "id": "intended-use", "name": "Intended use and function", "description": "What a MDMA is for, and what it is used for anyway.", "findings": [ { "id": "function-and-purpose", "name": "Function, purpose and misuse", "description": "The function a MDMA performs and the uses that fall outside it.", "questions": [ { "id": "function-and-purpose-q01", "text": "What identifies and describes the use of a MDMA, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "function-and-purpose-q02", "text": "Who or what asserted this about the use of a MDMA, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "function-and-purpose-q03", "text": "What may an agent decide or do once the use of a MDMA is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "handling-and-procedure", "name": "Handling and procedure", "description": "The steps, skills and tools involved in using a MDMA.", "findings": [ { "id": "procedures-and-skills", "name": "Procedures, skills and required tools", "description": "What an agent needs before it can act on a MDMA at all.", "questions": [ { "id": "procedures-and-skills-q01", "text": "What identifies and describes handling a MDMA, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "procedures-and-skills-q02", "text": "Who or what asserted this about handling a MDMA, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "procedures-and-skills-q03", "text": "What may an agent decide or do once handling a MDMA is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "supply-and-consumption", "name": "Supply and consumption", "description": "Quantities, rates and what running out means.", "findings": [ { "id": "consumption-and-stock", "name": "Consumption, stock and replenishment", "description": "How much of a MDMA there is and how fast it goes.", "questions": [ { "id": "consumption-and-stock-q01", "text": "What identifies and describes the supply of a MDMA, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "consumption-and-stock-q02", "text": "Who or what asserted this about the supply of a MDMA, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "consumption-and-stock-q03", "text": "What may an agent decide or do once the supply of a MDMA is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "composition-and-identity", "name": "Composition, grade and chemical identity", "description": "What MDMA is made of and how pure the thing in hand is.", "rationale": "Grade decides what a substance may be used for, so a model that records only the name cannot support any decision about use.", "layers": [ { "id": "chemical-identity", "name": "Chemical identity", "description": "Formula, structure and the registry numbers that name it unambiguously.", "findings": [ { "id": "identity-record", "name": "Identity and registry numbers", "description": "What identifies this substance across suppliers and regulators.", "questions": [ { "id": "identity-record-q01", "text": "What formula, structure and registry identifiers name MDMA unambiguously?", "kind": "definition" }, { "id": "identity-record-q02", "text": "Which related substances share a name in common use but not an identifier?", "kind": "boundary" } ] } ] }, { "id": "grade-and-impurities", "name": "Grade, purity and impurities", "description": "The specification a batch meets and what else is in it.", "findings": [ { "id": "specification", "name": "Specification and assay", "description": "How purity is stated and measured, and which impurities matter.", "questions": [ { "id": "specification-q01", "text": "What grades of MDMA exist, how is purity assayed, and which impurities are limited?", "kind": "measurement" }, { "id": "specification-q02", "text": "Which use requires which grade, and what happens when a lower grade is substituted?", "kind": "action" } ] } ] } ] }, { "id": "properties-and-behaviour", "name": "Properties and behaviour", "description": "How MDMA behaves under conditions an agent can measure or change.", "rationale": "Physical constants are the part of a substance model that transfers between contexts, and each needs its unit and its conditions.", "layers": [ { "id": "physical-constants", "name": "Physical constants", "description": "Values that hold for the pure substance, with their conditions.", "findings": [ { "id": "constants-record", "name": "Constants and conditions", "description": "The quantities worth recording and the state they apply in.", "questions": [ { "id": "constants-record-q01", "text": "What are the defining physical constants of MDMA, in what units and under what conditions?", "kind": "measurement" }, { "id": "constants-record-q02", "text": "Which of these values change with grade or form rather than being fixed?", "kind": "boundary" } ] } ] }, { "id": "stability-and-reactivity", "name": "Stability and reactivity", "description": "What it reacts with, degrades into, and how it is stored.", "findings": [ { "id": "incompatibilities", "name": "Incompatibilities and degradation", "description": "What must not meet it, and what it becomes over time.", "questions": [ { "id": "incompatibilities-q01", "text": "What is MDMA incompatible with, and what does it degrade into under storage?", "kind": "definition" }, { "id": "incompatibilities-q02", "text": "What storage and handling does that require, and who is competent to do it?", "kind": "action" } ] } ] } ] }, { "id": "hazard-and-regulation", "name": "Hazard classification and regulation", "description": "How MDMA can harm, and what the law says about holding and moving it.", "rationale": "A substance model without its hazard class and its regulatory identity is unusable in exactly the situations that matter.", "layers": [ { "id": "hazard-class", "name": "Hazard classification", "description": "Classified hazards, exposure limits and protective measures.", "findings": [ { "id": "classified-hazards", "name": "Classified hazards and limits", "description": "The classification, the scheme it belongs to, and the limits set.", "questions": [ { "id": "classified-hazards-q01", "text": "How is MDMA classified for hazard, under which scheme, and what exposure limits apply?", "kind": "definition" }, { "id": "classified-hazards-q02", "text": "What protection does handling require, and what must an agent refuse to do without it?", "kind": "action" } ] } ] }, { "id": "regulatory-identity", "name": "Regulatory identity and control", "description": "Registration, restriction and transport rules by jurisdiction.", "findings": [ { "id": "controls", "name": "Controls and jurisdiction", "description": "Where it is restricted and what the restriction attaches to.", "questions": [ { "id": "controls-q01", "text": "Which registrations, restrictions or transport rules cover MDMA, and where?", "kind": "provenance" }, { "id": "controls-q02", "text": "Does the control attach to the substance, its concentration, or its intended use?", "kind": "boundary" } ] } ] } ] }, { "id": "provenance-and-evidence", "name": "Provenance, evidence and time", "description": "Where every claim about a MDMA came from and when it held.", "rationale": "A claim without a source and a time cannot be superseded, only overwritten, and an agent that overwrites loses the ability to explain itself.", "layers": [ { "id": "source-and-authority", "name": "Source and authority", "description": "Who said it, on what evidence, and how strongly.", "findings": [ { "id": "claim-provenance", "name": "Claim provenance and confidence", "description": "The authority behind each claim about a MDMA and how confident it is.", "questions": [ { "id": "claim-provenance-q01", "text": "What identifies and describes a claim about a MDMA, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "claim-provenance-q02", "text": "Who or what asserted this about a claim about a MDMA, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "claim-provenance-q03", "text": "What may an agent decide or do once a claim about a MDMA is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "time-and-versions", "name": "Time, versions and supersession", "description": "When a claim was true, when it was learnt, and what replaced it.", "findings": [ { "id": "validity-and-supersession", "name": "Validity period and supersession", "description": "How an old claim about a MDMA is retired without being erased.", "questions": [ { "id": "validity-and-supersession-q01", "text": "What identifies and describes the validity of a claim about a MDMA, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "validity-and-supersession-q02", "text": "Who or what asserted this about the validity of a claim about a MDMA, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "validity-and-supersession-q03", "text": "What may an agent decide or do once the validity of a claim about a MDMA is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] } ] }, "statistics": { "bundles": 9, "layers": 20, "findings": 22, "questions": 60 } } } }